Intravenous thrombolysis for acute ischemic stroke in the extended time window of 4.5–24 h: a systematic review and network meta-analysis of randomized controlled trials - Scorecard - MDSpire

Intravenous thrombolysis for acute ischemic stroke in the extended time window of 4.5–24 h: a systematic review and network meta-analysis of randomized controlled trials

  • By

  • Xiaoqi Yu

  • Xiuye Sun

  • Fang Yang

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke within a 4.5 to 24-Hour Time Frame: A Systematic Review and Network Meta-Analysis of Randomized Trials

At a Glance

CategoryDetail
Condition
Key MechanismsIntravenous thrombolysis using plasminogen activators to dissolve blood clots.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              Intravenous thrombolysis for acute ischemic stroke in the extended time window of 4.5–24 h: a systematic review and network meta-analysis of randomized controlled trials

              • by Xiaoqi Yu, Xiuye Sun, Fang Yang

              • May 29, 2026

              Related Content

              Systemic immune-inflammation index predicts post-thrombectomy outcomes and reveals a mediating role in the association between neurocardiac stress and prognosis: a multicenter study

              A vitamin-biomarker risk score for 90-day functional outcome after acute ischemic stroke: development and internal validation in a retrospective cohort

              Predicting neurodevelopmental outcomes in neonatal hyperbilirubinemia: a multidimensional nomogram integrating biomarkers and neurobehavioral scores